DK0887350T3 - Nye chromenderivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende disse - Google Patents

Nye chromenderivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende disse

Info

Publication number
DK0887350T3
DK0887350T3 DK98401541T DK98401541T DK0887350T3 DK 0887350 T3 DK0887350 T3 DK 0887350T3 DK 98401541 T DK98401541 T DK 98401541T DK 98401541 T DK98401541 T DK 98401541T DK 0887350 T3 DK0887350 T3 DK 0887350T3
Authority
DK
Denmark
Prior art keywords
alkyl
sigma bond
optionally substituted
processes
preparation
Prior art date
Application number
DK98401541T
Other languages
Danish (da)
English (en)
Inventor
Gilbert Lavielle
Thierry Dubuffet
Patrick Hautefaye
Francoise Lejeune
Mark Millan
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of DK0887350T3 publication Critical patent/DK0887350T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK98401541T 1997-06-24 1998-06-23 Nye chromenderivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende disse DK0887350T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9707839A FR2764890B1 (fr) 1997-06-24 1997-06-24 Nouveaux derives chromeniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
DK0887350T3 true DK0887350T3 (da) 2001-10-08

Family

ID=9508333

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98401541T DK0887350T3 (da) 1997-06-24 1998-06-23 Nye chromenderivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende disse

Country Status (20)

Country Link
US (3) US6090837A (hu)
EP (1) EP0887350B1 (hu)
JP (1) JP4065604B2 (hu)
CN (1) CN1100057C (hu)
AT (1) ATE204578T1 (hu)
AU (1) AU735062B2 (hu)
BR (1) BR9802212A (hu)
CA (1) CA2242015C (hu)
DE (1) DE69801400T2 (hu)
DK (1) DK0887350T3 (hu)
ES (1) ES2163239T3 (hu)
FR (1) FR2764890B1 (hu)
GR (1) GR3037038T3 (hu)
HK (1) HK1016987A1 (hu)
HU (1) HU222728B1 (hu)
NO (1) NO323575B1 (hu)
NZ (1) NZ330787A (hu)
PL (1) PL192783B1 (hu)
PT (1) PT887350E (hu)
ZA (1) ZA985501B (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5134477A (en) * 1990-12-11 1992-07-28 At&T Bell Laboratories Hdtv receiver
FR2764890B1 (fr) * 1997-06-24 1999-08-27 Adir Nouveaux derives chromeniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AR022228A1 (es) 1999-01-12 2002-09-04 Abbott Gmbh & Co Kg Compuestos de triazol, composicion farmaceutica que los comprende y uso de los mismos para la preparar dicha composicion
US20040077605A1 (en) * 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
EP1854798A3 (en) * 2000-09-19 2007-11-28 Bristol-Myers Squibb Company Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US20040087548A1 (en) 2001-02-27 2004-05-06 Salvati Mark E. Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
FR2823752B1 (fr) * 2001-04-18 2004-10-22 Servier Lab Nouveaux derives de pyrimidin-4-ones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
TWI263640B (en) * 2001-12-19 2006-10-11 Bristol Myers Squibb Co Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
ATE404544T1 (de) * 2001-12-19 2008-08-15 Bristol Myers Squibb Co Kondensierte heterocyclische verbindungen und deren analoga; modulatoren der funktion von nukleären hormonrezeptoren
TW200400963A (en) 2002-05-21 2004-01-16 Wyeth Corp R-enantiomers of pyranoindole derivatives and the use thereof for the treatment of hepatitis C virus infection or disease
TW200400818A (en) 2002-05-21 2004-01-16 Wyeth Corp Method for the use of pyranoindole derivatives to treat infection with hepatitis C virus
US7765162B2 (en) * 2002-10-07 2010-07-27 Mastercard International Incorporated Method and system for conducting off-line and on-line pre-authorized payment transactions
DE102005005397B4 (de) * 2005-02-05 2008-08-21 Lts Lohmann Therapie-Systeme Ag Isolierung von N-Butylbenzolsulfonamid, Synthese von Benzolsulfonamid-Derivaten sowie Verwendung von N-Butylbenzolsulfonamid und Benzolsulfonamid-Derivaten zur Behandlung der benignen Prostatahyperplasie und/oder des Prostatakarzinoms
WO2007098462A2 (en) * 2006-02-21 2007-08-30 Purdue Research Foundation Trans-fused chromenoisoquinolines, synthesis and methods for use
EP2421862B1 (en) 2009-04-21 2014-06-11 Purdue Research Foundation Octahydrobenzoisoquinoline modulators of dopamine receptors and uses therefor
FR2948372B1 (fr) * 2009-07-21 2011-07-22 Servier Lab Nouveaux derives chromeniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN111647003B (zh) * 2020-06-08 2022-06-21 中国科学院昆明植物研究所 三环氧六氢色酮a及其药物组合物和其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2722194B1 (fr) * 1994-07-06 1996-08-23 Adir Nouveaux derives de benzopyrane, leur procede de preparation et les compositions pharmacuetiques qui les contiennent
GB9612153D0 (en) * 1996-06-11 1996-08-14 Smithkline Beecham Plc Compounds
FR2764890B1 (fr) * 1997-06-24 1999-08-27 Adir Nouveaux derives chromeniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
US6326377B1 (en) 2001-12-04
CN1100057C (zh) 2003-01-29
US6365605B1 (en) 2002-04-02
DE69801400D1 (de) 2001-09-27
NZ330787A (en) 1999-04-29
BR9802212A (pt) 1999-05-25
ES2163239T3 (es) 2002-01-16
AU735062B2 (en) 2001-06-28
NO323575B1 (no) 2007-06-11
CA2242015C (fr) 2005-01-04
ATE204578T1 (de) 2001-09-15
CN1203235A (zh) 1998-12-30
DE69801400T2 (de) 2002-05-16
FR2764890B1 (fr) 1999-08-27
ZA985501B (en) 1999-01-20
HU222728B1 (hu) 2003-09-29
JPH1171376A (ja) 1999-03-16
JP4065604B2 (ja) 2008-03-26
EP0887350B1 (fr) 2001-08-22
US6090837A (en) 2000-07-18
GR3037038T3 (en) 2002-01-31
AU7314098A (en) 1999-01-07
NO982921D0 (no) 1998-06-23
CA2242015A1 (fr) 1998-12-24
PL327002A1 (en) 1999-01-04
NO982921L (no) 1998-12-28
EP0887350A1 (fr) 1998-12-30
HUP9801423A3 (en) 1999-04-28
PT887350E (pt) 2001-11-30
HUP9801423A2 (hu) 1999-03-29
HK1016987A1 (en) 1999-11-12
PL192783B1 (pl) 2006-12-29
FR2764890A1 (fr) 1998-12-24
HU9801423D0 (en) 1998-08-28

Similar Documents

Publication Publication Date Title
DK0887350T3 (da) Nye chromenderivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende disse
DE69117828D1 (de) Anionische Verbindungen
EP0558635A4 (en) Improved matrix metalloprotease inhibitors
DE69420564D1 (de) Immunsuppressive und antiallergische verbindungen; z.b. n-(3-oxohexanoyl)-homoserinlacton
EP0539588A4 (hu)
PT1140916E (pt) Acetais heteroarilo ciclicos
MX9604398A (es) Derivados de sulfonamida.
AU5455996A (en) New alkoxyaryl compounds, their processes of preparation and the pharmaceutical compositions which contain them
TW333532B (en) Benzopyrans
ATE166875T1 (de) Ellipticinderivate mit antitumorwirkung
DK0873993T3 (da) Hidtil ukendte heterocykliske forbindelser, fremgangsmåde til deres fremstilling og sammensætninger indeholdende dem
FI874299A (fi) Foerfarande foer framstaellning av belaeggning genom straolningskorsbindning.
ATE281452T1 (de) 4-amino-2-ureido-pyrimidin-5-carbonsäureamide, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
NZ238644A (en) 2-(1-oxo-alkoxy)alkanoic acid derivatives and pharmaceutical compositions thereof
SU1783778A1 (ru) Производные 4-(1-окси-1-аминокарбонил-2,2,2-трифторэтил)-n-этиланилинов, обладающие антидотной активностью к хлорсульфурону
AU4878479A (en) Clavulanic acid derivatives